Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Latest-Generation IGRT Technology

By HospiMedica staff writers
Posted on 27 May 2005
A latest-generation linear accelerator has been developed for image-guided radiotherapy (IGRT) applications.

The new system is equipped with multilaminas, minimultilaminas, portal vision, and a Moduleaf system as an extra capability of minilaminas of 2.5 mm--the thinnest that currently exists in this technology--that can shape irregular portions of tumors with much greater precision. More...
Up to now, laminas of 1 cm have been used, in which the dosimetric yield is less exact in the instance of small lesions. The new system, developed by Siemens Medical Solutions (Erlangen, Germany), enables the application of very precisely-adapted treatments such as radiotherapy stereotactics, radiosurgery, and modulated intensity treatment. Using minimultilaminas, users can modulate the beam intensity at smaller volumes of tissue, thereby providing a greater number of applications.

This system has just been installed at the Navarra University Hospital
(Spain; www.unav.es) and is particularly useful for the treatment of brain tumors that are small and of irregular shape, both malignant and benign, as well as cerebral functional pathology. The system can be used as a therapeutic alternative for selected lung tumors, spinal tumors close to the spinal cord, and tumors at the base of the cranium.

Additionally, the new accelerator is capable, by means of its portal vision, of accurately comparing the radiation field in real time with the computer-designed one, and in this way, in situ corrections for deviations in the positioning of the patient can be carried out, or for the movements in the organ itself where the tumor can vary daily, and finally, for alterations in the size of the tumor as a response to the treatment.

Finally, the system can also deliver the traditional form of treatment--tridimensional and modulated radiotherapy with conventional laminas, thereby being complementary to the rest of the latest technologies in the cancer diagnosis and treatment field.






Related Links:
Siemens Medical Solutions

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.